drugset / Trial / NCT04142840

Dexmedetomidine and Propofol in the Treatment of Emergence Agitation

NCT04142840

Phase 0 Unknown 120 enrolled RenJi Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

1. This clinical research aims to compare the effects of dexmedetomidine and propofol on the treatment of emergence agitation in adult patients after general anesthesia. 2. Half of participants will receive dexmedetomidine while the other half will receive propofol when emergence agitation happens.

Timeline

Start
2019-11-01
Primary completion
2021-08-30
Completion
2021-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.7 ug/kg
Comparator Propofol Small molecule 0.5 mg/kg

Indications

No indication recorded.